| Cell line name |
MA148 |
| Synonyms |
MA 148; MA-148 |
| Accession |
CVCL_AK47 |
| Resource Identification Initiative |
To cite this cell line use: MA148 (RRID:CVCL_AK47) |
| Comments |
Derived from site: In situ; Ovary; UBERON=UBERON_0000992. |
| Disease |
Ovarian cystadenocarcinoma (NCIt: C5228) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Sex of cell |
Female |
| Age at sampling |
Age unspecified |
| Category |
Cancer cell line |
| Publications | PubMed=8640821 Sundaram Ramakrishnan, Timothy A. Olson, Victoria L. Bautch, Mohanraj Dhanabal; Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res. 56:1324-1330(1996) PubMed=10786683 Yumi Yokoyama, Mohanraj Dhanabal, Arjan W. Griffioen, Vikas P. Sukhatme, Sundaram Ramakrishnan; Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res. 60:2190-2196(2000) PubMed=12361951; DOI=10.1074/jbc.M207937200 Sarah L. Donahue, Colin Campbell; A DNA double strand break repair defect in Fanconi anemia fibroblasts. J. Biol. Chem. 277:46243-46247(2002) PubMed=19926575; DOI=10.1309/AJCPTK87EMMIKPFS; PMCID=PMC3040237 Melissa S. DeRycke, John D. Andersen, Katherine M. Harrington, Stefan Eduard Pambuccian, Steve E. Kalloger, Kristin L.M. Boylan, Peter Alexander Argenta, Amy Patrice Norden Skubitz; S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival. Am. J. Clin. Pathol. 132:846-856(2009) |
| Cross-references |
| Encyclopedic resources |
Wikidata; Q54903894
|
| Entry history |
| Entry creation | 02-May-2016 |
| Last entry update | 29-Jun-2023 |
| Version number | 6 |
|---|